JAKAFI®: Addressing Overall Survival and Splenomegaly in Patients With Myelofibrosis Regardless of Anemia | Intervene With Jakafi® (ruxolitinib) at Diagnosis
This event begins in
- Days
- Hours
- Minutes
A zoom link will be available the day of the event.
- May 27, 2026
- 8:00 PM EST
National Cornerstone Corner, 8:00PM
Program Chairs
Sponsors
This program is not CME accredited.
In addition to the Program's educational offerings, a separate portion involves market research sessions for which a fair market value honorarium will be offered to eligible registrants who choose to participate. Additional details are listed on the registration page and dependent on registrant's designation.
